malaria_record: 133

Data license: Public Domain (CDC) · Data source: CDC Travelers' Health (Yellow Fever & Malaria, by country)

This data as json

record_id country_id valid_from valid_to is_current source_id fetch_run_id payload_sha256 content_hash area_of_risk_html relative_risk_html chloroquine_resist_html species_html recommended_prophylaxis_html cdc_updated_date has_transmission is_endemic whole_country_endemic country_has_any_prophylaxis_area screening_class prophylaxis_drugs_json species_json chloroquine_resistant area_summary created_at
133 133 2026-06-03   1 1 1 8eab5796788447f748d742bc3ea9c689b7dd02e0761828d2fa9fd151f54f3515 ec44011d69ae8878623946465a5999690160a64499fd5e5aa33ac735a85595fa
  • Primarily the provinces that border Burma (Myanmar), Cambodia (rare cases in Buri Ram Province), and Malaysia (especially in the rural forest and forest-fringe areas of these provinces)
  • Rare to few cases in other parts of Thailand, including the cities of Bangkok (the capital), Chiang Mai, and Chiang Rai, or on the islands of Koh Pha Ngan, Koh Samui, or Phuket
  • No malaria transmission on the islands of Krabi Province (Koh Lanta, Koh Phi Phi, Koh Yao Noi, Koh Yao Yai) or in Pattaya City
  
  • Chloroquine and mefloquine
  • P. vivax (80%)
  • P. falciparum (<20%)
  • P. knowlesi,6 P. malariae, and P. ovale (rare)
  • Provinces that border Burma (Myanmar), Cambodia (except Buri Ram Province), and Malaysia: Atovaquone-proguanil, doxycycline, tafenoquine2
  • All other areas with malaria transmission (including Buri Ram province): No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4
Updated April 23, 2025
 2025-04-23 1 1 0 1 partial ["atovaquone-proguanil", "doxycycline", "tafenoquine"] ["P. falciparum", "P. knowlesi", "P. malariae", "P. ovale", "P. vivax"] 1 2 risk area statement(s); 1 no-transmission exclusion(s) 2026-06-03T22:10:28Z

Links from other tables